CVRx Inc (CVRX)
8.765
+0.22
(+2.63%)
USD |
NASDAQ |
Oct 04, 16:00
8.765
0.00 (0.00%)
After-Hours: 20:00
CVRx SG&A Expense (TTM): 82.10M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 82.10M |
March 31, 2024 | 77.44M |
December 31, 2023 | 64.51M |
September 30, 2023 | 61.60M |
June 30, 2023 | 58.63M |
March 31, 2023 | 54.66M |
December 31, 2022 | 50.04M |
September 30, 2022 | 45.61M |
Date | Value |
---|---|
June 30, 2022 | 41.04M |
March 31, 2022 | 34.18M |
December 31, 2021 | 27.86M |
September 30, 2021 | 21.46M |
June 30, 2021 | 15.68M |
March 31, 2021 | 11.88M |
December 31, 2020 | 9.717M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
9.717M
Minimum
Dec 2020
82.10M
Maximum
Jun 2024
43.76M
Average
45.61M
Median
Sep 2022
SG&A Expense (TTM) Benchmarks
NeuroOne Medical Technologies Corp | 7.637M |
SINTX Technologies Inc | 5.115M |
Nutriband Inc | 4.072M |
enVVeno Medical Corp | 10.93M |
Beyond Air Inc | 33.64M |